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a la solubilidad de la mitomicina C en mezclas
etanol + agua
Application of the Extended Hildebrand
solubility approach applied to mitomycin C
in ethanol + water mixtures
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Resumen
En este trabajo se aplicó el método extendido de solubilidad de Hildebrand (MESH) para evaluar la solubilidad
de mitomicina C en mezclas etanol + agua a 293,15 K. Se reporta la solubilidad experimental y algunas
propiedades de fusión de éste fármaco que fueron utilizados para los cálculos del método extendido de
Hildebrand. En particular, EHSA presenta un buen carácter predictivo mediante el uso de un polinomio
regular de orden cinco para el parámetro de interacción W en una función del parámetro de solubilidad de
mezclas cosolvente libre de fármaco.
Palabras clave: Mitomicina; Etanol; Mezclas binarias; Método extendido Hildebrand; parámetros de
solubilidad.
Abstract
In this work, we applied the extended Hilderband solubility approach (EHSA) to evaluate the solubility of
mitomycin C in ethanol-water mixtures at 293.15 K. We report the experimental solubility and some of the
drug’s fusion properties that were used for the calculations in the extended Hilderband approach. In parti-
cular, EHSA presents good predicative properties by means of a regular fifth-degree polynomial for interaction
parameter W in a function of the solubility parameter of solvent mixtures without the drug.
Key words: Mitomycin, etanol; binary mixtures, extended Hildebrand solubility approach; solubility
parameters.
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1. Introduction




Registry No.: 50-07-7) (Gandhi and Murthy, 2012) is
an antibiotic and anti-neoplastic material isolated from
the broth of Streptomyces caespitosus and is one of
the naturally occurring antibiotics that was first
discovered in 1956 (Hata, et al., 1956). This drug has
been demonstrated to have antifibroblastic activity in
vitro and in vivo (Unal, 2004). It is an antineoplastic
antibiotic that acts as an alkylating agent by inhibiting
DNA and protein synthesis. It can inhibit cell division,
protein synthesis, and fibroblast proliferation (Rahbar,
et al., 2000). Despite the usefulness of these drugs,
their physicochemical properties in aqueous solution
have not yet studied completely (Budavari, et al., 2001;
Gandhi and Murthy, 2012). In particular, it is well known
that their solubilities in neat aqueous media are very
low (Jouyban, 2010). It is noteworthy that cosolvency
is the best technique used in pharmacy for increasing
drugs solubility (Rubino, 1988; Yalkowsky, 1999). On
the other hand, it is clear that predictive methods of
physicochemical properties of drugs, in particular the
ones intended to estimate solubilities, are very important
for industrial pharmacists because they allow optimizing
several design processes (Budavari, 2001; Martin, et
al., 1993; Regosz, et al., 1992; Martínez and Gómez,
2002; Hanaee, et al., 2005).
For this reason, this work presents a physicochemical
study about the solubility prediction of the mitomycin
C, in binary mixtures conformed by ethanol (EtOH)
and water at 293.15 K. The study was done based on
the Extended Hildebrand Solubility Approach (EHSA)
(Martin, et al., 1993; Martin and Bustamante, 1989;
Martínez, 2005) by using experimental solubility values
and some properties relative to the fusion of these drugs
taken from the literature (Gandhi and Murthy, 2012).
It is important to keep in mind that EHSA method has
been widely used to study the solubility of a lot of
pharmaceutical compounds as has been recently
exposed in the literature (Holguín, et al., 2012).
Furthermore, it is still employed to evaluate the behavior
of drugs in several co-solvent mixtures (Sotomayor, et
al., 2013; Cristancho, et al., 2013; Gómez, et al., 2013;
Rathi, 2011; Dehpande, et al., 2014). On the other hand,
it is remarkable that EtOH is one of the more employed
co-solvent to develop liquid pharmaceutical dosage
forms because of its solubilizing and antimicrobial
properties (Smolinske, 1992; Aulton, 2002).
2. Theoretical
The ideal solubility ( ) of a solid solute is calculated
by means of the expression,
  
(1)
where, ΔHfus is the molar enthalpy of fusion of the pure
solute (at the melting point), Tfus is the absolute melting
point, T is the absolute solution temperature, R is the
gas constant (8.314 J mol–1 K–1), and ΔCp is the
difference between the molar heat capacity of the
crystalline form and the molar heat capacity of the
hypothetical supercooled liquid form, both at the
solution temperature. Since ΔCp cannot be easy
experimentally determined, this property may be
approximated to the entropy of fusion, ΔSfus. Ideal
solubility depends only on the physicochemical
properties of the solid compound without considering
the properties of the solvent. For this reason the ideal
solubility would be higher as the solute-solute inte-
ractions are lower (Gandhi and Murthy, 2012).
Accordingly, compounds with high values of melting
point and enthalpy of fusion have lower ideal solubilities.
On the other hand, the real solubility (X3) of a solid
solute in a liquid solution is calculated by means of the
expression,
         (2)
where, log γ3 is the non-ideality term, being γ3 the solute
activity coefficient, which is determined experimentally.Figura 1. Molecular structure of Mitomycin C.
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Nevertheless, one method of calculating γ3 is the
referent to regular solutions obtained from,
        (3)
where, V3 is the partial molar volume of the solute, φ1
is the volume fraction of the solvent in the saturated
solution, and δ1 and δ3 are the solubility parameters of
solvent and solute, respectively. φ1 is calculated as,
       (4)
where V1 is the molar volume of solvent.
Nevertheless, all the pharmaceutical dissolutions
deviate of predicted by the regular solutions theory.
For this reason, Martin et al. developed the EHSA
method (Martin and Carstense, 1980; Martin and Wu,
1981; Martin and Miralles, 1982; Martin, et al., 1981,
1982, 1985). Thus, if the A term (defined as
) is introduced in the Eq. (3), the real
solubility of drugs can be calculated from the
expression, X3
                       (5)
where, the W term is equal to 2Kδ1δ3 (where, K is
the Walker parameter (Martínez and Gómez, 2002).
The W factor can be calculated from experimental
data by means of,
                                                                      (6)
where, γ3 is the activity coefficient of the solute in the
saturated solution, and it is calculated as,  .
The experimental values of the W parameter can be
correlated by means of regression analysis by using
regular polynomials as a function of d1, as follows,
   (7)
These empiric models can be used to estimate the drug
solubility by means of back-calculation resolving this
property from the specific W value obtained in the res-
pective polynomial regression.
3. Results and discussion
The required properties about the mitomycin C studied,
like ideal solubility, molar volume and Hildebrand
solubility parameter (Table 1), was calculated from the
drug thermodynamic data reported previously in the
literature (Gandhi and Murthy, 2012); whereas, the
volumetric behavior and polarity of EtOH + water
mixtures, as a function of the composition, is shown in
Table 2 (Gandhi and Murthy, 2012). Volume fractions
and Hildebrand solubility parameters were calculated
assuming additive behavior (Martin, et al., 1993;
Connors, 2002). Table 2 also summarizes the experi-
mental solubility of the mitomycin expressed in mole
fraction reported in the literature (Gandhi and Murthy,
2012), including ideal solubility.
Figure 2 shows the ideal and experimental solubility,
as well as the calculated solubility by using the regular
Table 1. Interne energy, molar volume and Hildebrand solubility parameter of mitomycin C according to the Fedors method.
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Table 2. Ethanol + water solvent mixtures composition,
Hildebrand solubility parameter of mixtures and solubility
of mitomycin expressed in mole fraction, including ideal
solubility at 293.15 K.
Figure 2. Ideal solubility (), experimental solubility () and calculated solubility according to the
regular solutions model of Hildebrand () of mitomycin C as a function of the solubility parameter in
ethanol + water mixtures at 293.15 K.
solution model, i.e. Eq. (3), as a function of the solubility
parameter of solvent mixtures, from 26.5 to 47.8 MPa1/2.
In order to use Eq. (3) the molar volume and Hildebrand
solubility parameter of the mitomycin C, estimated
according to the groups contribution method proposed
by Fedors, is 26.70 MPa1/2 Table 1 (Fedors, 1974). It
is important to keep in mind that according to regular
solutions model the maximum solubility value
corresponds to the ideal solubility and it is obtained just
when both solubility parameters of drug and solvent
mixture are coincident, like it is shown in Fig. 2. On
the other hand, according to the literature the maximum
experimental solubility values are found when the
solubility parameters of both solute and solvent are also
coincident (Martin and Bustamante, 1993, 1989).
Nevertheless, in the present case the experimental drug
solubilities are lower than the calculated according to
Eq. (3) in all the compositions for the mitomycin C.
The φ1 values calculated according to Eq. (4) are almost
equal to 1.000 because the solubility of mitomycin C is
very low in all the solvent system considered, varies
form 0.9997 and 0.9888 in EtOH-rich mixtures due to
its high solubility (Table 3). Otherwise, the activity
coefficients of mitomycin C expressed as decimal
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logarithms are also presented in Table 3. This table
also summarizes the parameters A, K, and W for the
mitomycin C in EtOH + water mixtures; whereas,
Figure 3 shows that the variation of the W parameter
with respect to the solubility parameter of solvent
mixtures, presents deviation from linear behavior, just
as it is expectable because the W term implies the
summation of two quadratic (  and ) and one non-
constant-quotient (–log δγ2 / A) terms, as Eq. (6) shows.
W values were adjusted to regular polynomials in
orders from 2 to 5 (Eq. 7). Linear equation was also
considered just as comparison. Table 4 summarizes
the coefficients obtained in all the regular polynomials
Figure 3. W parameter of mitomycin C in ethanol + water mixtures as a function of the solubility
parameter of the solvent mixtures at 293.15 K.
Table 3. Volume fraction of solvent, mitomicyn C activity coefficients, A, K, and W experimental parameters of mitomycin C
in ethanol + water mixtures at 293.15 K.
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for the mitomycin. The significant figures in the
coefficients and uncertainties were defined
according to the criterion 3-30, when that was
possible (Shoemaker and Garland, 1968). Briefly, this
criterion establishes that the numeric quantity in
uncertainty should be placed between 3 and 29,
without consider decimal positions, except if they
integers greater than 30. In this way the number of
Table 5. Calculated solubility of mitomicyn C in ethanol + water mixtures by using the W parameters obtained from
regression models in orders 1, 2, 3, 4 and 5, and standard deviations with respect to the experimental values, at 293.15 K.
Table 4. Coefficients and statistical parameters of regular polynomials in several orders of W as a function of solubility
parameters of co-solvent mixtures free of mitomycin C (Eq. 7) in ethanol + water mixtures at 293.15 K. Values in parentheses
are the respective uncertainties.
decimal places for the coefficients is defined
according to the decimal places of the respective
uncertainties.
It is found that as more complex the polynomial used
is, better the agreement found between experimen-
tal and calculated solubility also is. Accordingly, the
most important increment in concordance is obtained
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passing from order 1 to order 2. The concordances
also increase in good way from order 2 to 3 and
from order 3 to 4. In the last case the mean uncer-
tainties obtained are in the same order or lower than
those reported experimentally (Gandhi and Murthy,
2012). It is important to keep in mind that for
pharmaceutical purposes uncertainties lower than
5% are useful for practical purposes but for
academic purposes best agreements are required.
In this way, although an additional improves is
obtained by passing from order 4 to 5 this result is
not relevant because the mean uncertainties are
lower in comparison with those reported for experi-
mental values (Gandhi and Murthy, 2012).
As has been previously described, a very important
consideration about the usefulness of the EHSA method
is the one referent to justify the complex calculations
involving any other experimental variables of solute
and solvents, instead of the simple empiric regression
of the experimental solubility as a function of the
solubility parameters of solvent mixtures as shown in
Fig. 3. For this reason, Table 6 shows the coefficients
of regular polynomials in order 4 of log X3 as a function
of d1 values (Eq. 8). The significant figures in the
coefficients and uncertainties were also defined
Figure 3. Logarithmic solubility of mitomycin C in etanol + water mixtures as a function of the solubility
parameter of the solvent mixtures at 293.15 K. Dotted lines are the additive solubility behavior.
Table 6. Coefficients and statistical parameters of regular
polynomials in fourth degree of log X3 as a function of
solubility parameters of cosolvent mixtures free of
Mitomycin C (Eq. 8) in ethanol + water mixtures. Values in
parentheses are the respective uncertainties.
according to the criterion 3-30 (Shoemaker and
Garland, 1968).
  (8)
On the other hand, Table 7 shows the calculated values
of solubility by using Eq. (8) in and also the respective
difference percentages in front the experimental ones.
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Based on mean deviation percentages presented in
Tables 5 and 7 it follows that no difference is found
between the values obtained by using both methods.
These results would show a non-significant usefulness
of EHSA method for practical and academic purposes
in the case of the mitomycin C studied. Nevertheless,
it is necessary keep in mind that this correlative method
considers the drug solubility from a systematic
physicochemical point of view. Moreover, it would just
be necessary to find an effective method to calculate
the Walker K parameter in order to calculate the W
term according to the expression W = 2Kd1d3, because
the d1 and d3 terms would be known, and thus, the
drug experimental solubility could be calculated in any
mixture (Martin and Bustamante, 1989).
4. Conclusions
In this investigation the extended Hildebrand solubility
approach has been adequately used to study the
solubility of mitomycin C in ethanol + water mixtures
at 293.15 K. In particular, a good predictive character
has been found by using a regular polynomial in order
five of the interaction parameter W as a function of
the solubility parameter of solvent mixtures free of drug.
Nevertheless, the predictive character of EHSA is the
same as the one obtained by direct correlation between
Table 7. Calculated solubility of Mitomycin C in ethanol +
water mixtures by using the equations of log X3 vs. ?1 as
regression models in order 4, and standard deviations with
respect to the experimental values, at 293.15 K.
mitomycin C solubility and the same descriptor of
polarity of the co-solvent mixtures.
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